Antibacterial Therapy of NeurosyphilisLack of Impact of New Therapies
作者:
Latisha Ali,
Karen L. Roos,
期刊:
CNS Drugs
(ADIS Available online 2002)
卷期:
Volume 16,
issue 12
页码: 799-802
ISSN:1172-7047
年代: 2002
出版商: ADIS
关键词: Antibacterials, therapeutic use;Neurosyphilis, treatment;Penicillins, therapeutic use
数据来源: ADIS
摘要:
Neurosyphilis is caused by the spirocheteTreponema pallidum. These organisms divide slowly, requiring long exposure to antibacterials for treatment success. In order for an antibacterial to be effective in the therapy of neurosyphilis, it must achieve treponemicidal concentrations in the CSF, have a long half-life and be given in a treatment regimen that favours compliance. Penicillin was first introduced for the treatment of syphilis in 1943, and despite interest in the use of amoxicillin, erythromycin, tetracycline, doxycycline, ceftriaxone and azithromycin, penicillin remains the only recommended antibacterial agent for neurosyphilis.
点击下载:
PDF
(182KB)
返 回